Skip to content
Homepage
Clinic directory

Clinics in Seattle, Washington

Every listing is checked against federal records, reviewed for evidence, and confirmed still operating. No pay-to-play. No guesswork.

  • No results found.
  • No results found.

Seattle, WA

Psychedelic Therapy clinics in Seattle

Psychedelic-assisted therapy in Seattle sits mostly in the ketamine-assisted psychotherapy category, with some clinics also preparing for state-specific psilocybin frameworks. Psychiatric referrals for complex cases route through UW Medicine, Virginia Mason Franciscan, Swedish, and Seattle Children's. Demand reflects a tech-industry and naturopathic-friendly population.

Ketamine-assisted psychotherapy has the strongest US evidence base among psychedelic modalities. Psilocybin is not FDA approved and is only legally accessible within research or specific state programs. MDMA therapy is investigational. Clinics in Seattle, Washington should be evaluated for therapist training, safety protocols, and honest evidence framing. Washington state expansive naturopathic licensure determines what can legally be offered.

With psychedelic therapy clinics on Regenerated.com in Seattle, patients can compare clinician training, integration support, and legal framework before booking.

7 Clinics

MD on staff

Meirapsychotherapy

Seattle, WA

Meirapsychotherapy, a ketamine and psychedelic-assisted therapy clinic in Seattle, specializes in relational somatic approaches to treatment-resistant depression, anxiety, PTSD, and related condition…

  • Ketamine Therapy
  • Psychedelic Therapy

The Art of Healing Counseling

Seattle, WA

The Art of Healing Counseling, a mental-health clinic in Seattle, specializes in ketamine therapy and psychedelic-assisted psychotherapy for treatment-resistant depression, anxiety, PTSD, and related…

  • Ketamine Therapy
  • Psychedelic Therapy

Ash Anthony LMFT

Seattle, WA

Ash Anthony, LMFT, a somatic psychotherapist in Seattle, specializes in ketamine therapy and psychedelic-assisted psychotherapy for treatment-resistant depression, anxiety, PTSD, and trauma-related c…

  • Ketamine Therapy
  • Psychedelic Therapy
 MD on staff

Seattle Healing Arts Center

Seattle, WA

Seattle Healing Arts Center, an integrative practice in Seattle, combines family medicine and naturopathic approaches with ketamine and psychedelic-assisted psychotherapy. The clinic positions psyche…

  • Ketamine Therapy
  • Psychedelic Therapy

North Seattle Psychotherapy

Seattle, WA

North Seattle Psychotherapy, located in Seattle, offers ketamine therapy and psychedelic-assisted therapy for treatment-resistant depression, anxiety, and trauma-related conditions. Andrew Carnahan, …

  • Ketamine Therapy
  • Psychedelic Therapy

Palladium Mind

Seattle, WA

Palladium Mind, a mental-health clinic in Seattle, offers psychedelic-assisted therapy alongside hypnotherapy services. The practice focuses on supporting patients with treatment-resistant presentati…

  • Psychedelic Therapy

Syzygy Psychotherapy Collective

Seattle, WA

Syzygy Psychotherapy Collective, a mental-health clinic in Seattle, offers psychedelic-assisted therapy and ketamine therapy alongside evidence-based psychotherapeutic modalities including EMDR, Inte…

  • Transcranial Magnetic Stimulation (TMS)
  • Ketamine Therapy
  • Psychedelic Therapy
  • Hormone Replacement Therapy (HRT)
15 30 50 results per page

Regulatory context

A note on Washington's psychedelic therapy rules.

Ketamine is a DEA Schedule III controlled substance, FDA-approved as a dissociative anesthetic and used off-label for treatment-resistant depression, PTSD, and chronic pain. The FDA approved esketamine (Spravato) in 2019 for treatment-resistant depression under a Risk Evaluation and Mitigation Strategy (REMS) program that requires in-office administration at certified sites. MDMA-assisted therapy remains Schedule I; the FDA issued a Complete Response Letter in August 2024 to Lykos Therapeutics on its MDMA new drug application. Psilocybin is Schedule I and holds FDA Breakthrough Therapy designation through sponsors such as Compass Pathways and Usona, but has not received FDA approval. Oregon Measure 109 (passed 2020, operational 2023) created a state psilocybin service center framework, and Colorado Proposition 122 (2022) authorized regulated healing centers.

  • SB 5263 / Psilocybin Task Force (2023)
    Established a state psilocybin task force and authorized a pilot psilocybin services program for veterans and first responders, with UW School of Medicine oversight.
  • Local decriminalization
    Seattle (2021), Port Townsend, and Olympia have passed resolutions deprioritizing enforcement of entheogenic plants.
  • Washington Uniform Controlled Substances Act
    Mirrors federal scheduling.

Washington enforces federal scheduling outside the pilot program. The Washington Medical Commission oversees prescriber conduct. DEA enforcement on ketamine clinics focuses on diversion and Ryan Haight Act telehealth rules. Washington PMP requires controlled substance reporting. The UW-affiliated psilocybin pilot operates within federal research compliance.

Sources: dea.gov · doh.wa.gov · doh.wa.gov · app.leg.wa.gov

Psychedelic Therapy in Seattle, answered.

In Washington, ketamine-assisted psychotherapy is the primary legal option. Ketamine is a Schedule III controlled substance prescribed off label for depression, anxiety, and PTSD. Psilocybin and MDMA are Schedule I federally and not legally available in Washington. Only Oregon (Measure 109) and Colorado (Proposition 122) currently operate regulated psilocybin programs.

In Seattle, ketamine-assisted psychotherapy typically runs 400 to 900 dollars per session, with full protocols of six sessions costing 2,500 to 6,000 dollars. IM injection sessions tend to be less expensive than IV infusions. Spravato (esketamine nasal spray) is FDA-approved for treatment-resistant depression and may be covered by insurance with prior authorization, though out-of-pocket copays vary. Integration therapy sessions are often billed separately at 150 to 300 dollars each.

Not as an FDA-approved treatment. In August 2024 the FDA issued a Complete Response Letter to Lykos Therapeutics (formerly MAPS PBC) for MDMA-assisted therapy for PTSD, citing concerns about trial design and data quality. MDMA remains Schedule I federally. Some expanded access and clinical trial pathways exist, but no Seattle clinic can legally prescribe MDMA outside of those frameworks. Lykos has stated it plans to resubmit following additional trial work.

Ketamine-assisted psychotherapy is used off-label for treatment-resistant depression, PTSD, anxiety, and suicidal ideation. Spravato (esketamine) carries FDA approval specifically for treatment-resistant depression and major depressive disorder with acute suicidal ideation or behavior. Evidence quality is strongest for depression, with multiple randomized trials supporting short-term benefit. Seattle clinics typically screen for cardiovascular conditions, psychotic disorders, and active substance use before starting treatment.

Verify the prescriber on the Washington medical board license lookup and NPI registry. Confirm the clinician has training in psychedelic-assisted therapy through MAPS, Fluence, Polaris, or a comparable program. Ask about screening protocols, emergency procedures, and whether a therapist is present during sessions. Check the FDA warning letter database. Avoid clinics promising guaranteed outcomes, pushing large prepaid packages, or operating outside of state licensure. Integration support should be part of any reputable protocol.

Filters

Rating

Treatments

Advanced Therapies 1
Chronic, Immune & Hormonal
Digestive & Respiratory
IV & Infusion
Pain & Musculoskeletal
Skin & Aesthetics
Mental Health & Neurology